PAWS-GIST Research Projects
Research Initiatives
Since the start of PAWS-GIST in 2010 our aim has always been to stimulate research for improved treatments and a cure. It has taken a while as we needed first of all to set up The National GIST Tissue Bank, The PAWS-GIST clinic and then locate some researchers willing to work with us. However, our dream is beginning to come true...
Below is a list of PAWS-GIST research, much of which has been funded by donations and grants made to PAWS-GIST that are held by GIST Cancer UK.
It is only as a result of fundraising by family friends and supporters that this work can happen.
Thanks to everyone who has and continues to raise funds for PAWS-GIST, look at what you are helping us to achieve!

Wildtype SDH Deficient GIST in the UK; A review of clinical course, genetics, epigenetics and metabolomics.
Principal investigator (PI) - Dr Ruth Casey
Funding awarded by GCUK - £60,000
Project Duration - 3rd January 2017 to 31st December 2020.
Research outputs:
Dr Casey's research papers were published in PubMed as follows:
- 2017 - SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity. https://pubmed.ncbi.nlm.nih.gov/28546994/
- 2018 - Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utility. https://pubmed.ncbi.nlm.nih.gov/30949620/
- 2019 - SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice. https://pubmed.ncbi.nlm.nih.gov/31308404/
- 2020 - A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma. https://pubmed.ncbi.nlm.nih.gov/32686200/
- 2021 - Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2. https://pubmed.ncbi.nlm.nih.gov/33854214/
Next generation sequencing of WT GIST's to identify therapeutic targets.
Principal investigator (PI) - Dr Newton Wong
Funding awarded by GCUK - £15,389
Project Duration - 1st July 2017 - June 2020
Research outputs:
June 2020 - Dr Wong’s research paper “Next generation sequencing demonstrates the rarity of short kinase variants specific to quadruple wild type gastrointestinal stromal tumours”. Was published in the Journal of Clinical Pathology: http://dx.doi.org/10.1136/jclinpath-2020-206613
Research to investigate the potential of Gallium-68 (68Ga) DOTA-conjugated peptidePET/CT to develop theranostic applications in wild-type gastrointestinal stromal tumours (GISTs).
Principal investigator (PI) - Dr Ruth Casey
Funding awarded by GCUK - £21,000
Project Duration - Starting in 2019
Research outputs: TBC
Investigating the utility of serum miRNA as a tumour biomarker to guide surveillance in patients with dSDH GIST and PPGL.
Principal investigator (PI) - Dr Ruth Casey
Funding awarded by GCUK from the PAWS-GIST Research fund- £76,886
Project Duration - 2020 - December 2023
Research outputs: Preferential MGMT hypermethylation in SDH-deficient wild-type GIST
https://pubmed.ncbi.nlm.nih.gov/36198483/
Pilot Study - Altered RNA methylation in SDH deficient gastrointestinal stromal tumours
Principal investigator (PI) - Dr Olivier Giger
Funding awarded by GCUK - £7,000
Project Duration - March 2019 - September 2019
Research outputs: Preferential MGMT hypermethylation in SDH-deficient wild-type GIST
https://pubmed.ncbi.nlm.nih.gov/36198483/
Metabolic alterations and vulnerabilities of succinate dehydrogenase-deficient GIST
Principal investigator (PI) - Professor Eyal Gottlieb
Funding awarded by GCUK - No Funding (Tissue supplied by National GIST Tissue Bank)
Project Duration - Commenced 2018
Research outputs: TBC
Investigating the potential of deuterium metabolic imaging in SDH-deficient GIST
Principal investigator (PI) - Dr Mary McLean
Funding awarded by GCUK - £20, 475
Project Duration - October 2023 - September 2025
Research outputs: TBC
Establishing novel models of SDH-deficient/Wild-type GIST for the testing of novel therapeutic strategies
Principal investigator (PI) - Professor Zoe Walters
Funding awarded for consumables on this project - £31, 463
Project Duration - November 2024 - November 2026
Research outputs: TBC
SDH-deficient GISTs affect approximately 60, predominantly younger individuals annually in the UK. They exhibit distinct biological characteristics compared to other GISTs with different mutations. One major limitation to finding new treatments is the lack of models of these cancers that can be used in the laboratory to identify and test new treatments. This project aims to develop new laboratory models of SDH-deficient GISTs to provide a platform to test new drugs for patients and pave the way for rapid translation into clinical trials.




